Stephen Hoge Moderna, Inc. (MRNA) insider trading activity

Stephen Hoge is President of Moderna, Inc.. Currently has a direct ownership of 1.44 Million shares of MRNA, which is worth approximately $56.9 Million. The most recent transaction as insider was on Jun 02, 2023, when has been sold 309 shares (Common Stock) at a price of $130.32 per share, resulting in proceeds of $40,268. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.44M

0.06% 3M change

4.76% 12M change

Total Value Held $56.9 Million

Stephen Hoge Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 02 2023	SELL Open market or private sale	$40,268 $130.32 p/Share	309 Reduced 0.02%	1,632,303 Common Stock
Jun 01 2023	BUY Exercise of conversion of derivative security	-	651 Added 0.04%	1,632,612 Common Stock
May 30 2023	SELL Open market or private sale	$147,565 $124.95 p/Share	1,181 Reduced 0.07%	1,631,961 Common Stock
May 26 2023	BUY Exercise of conversion of derivative security	-	2,410 Added 0.15%	1,633,142 Common Stock
May 10 2023	SELL Open market or private sale	$33,342 $133.37 p/Share	250 Reduced 0.02%	1,630,732 Common Stock
May 09 2023	BUY Exercise of conversion of derivative security	-	522 Added 0.03%	1,630,982 Common Stock
Mar 02 2023	SELL Open market or private sale	$160,578 $136.43 p/Share	1,177 Reduced 0.07%	1,630,460 Common Stock
Mar 01 2023	SELL Open market or private sale	$147,968 $138.03 p/Share	1,072 Reduced 0.07%	1,629,031 Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	-	2,606 Added 0.16%	1,631,637 Common Stock
Feb 28 2023	BUY Exercise of conversion of derivative security	-	2,410 Added 0.15%	1,630,103 Common Stock
Feb 10 2023	SELL Open market or private sale	$40,155 $163.9 p/Share	245 Reduced 0.02%	1,627,693 Common Stock
Feb 09 2023	BUY Exercise of conversion of derivative security	-	522 Added 0.03%	1,627,938 Common Stock
Nov 29 2022	SELL Open market or private sale	$188,573 $173.8 p/Share	1,085 Reduced 0.07%	1,627,416 Common Stock
Nov 28 2022	BUY Exercise of conversion of derivative security	-	2,410 Added 0.15%	1,628,501 Common Stock
Nov 10 2022	SELL Open market or private sale	$38,251 $165.59 p/Share	231 Reduced 0.01%	1,626,091 Common Stock
Nov 09 2022	BUY Exercise of conversion of derivative security	-	522 Added 0.03%	1,626,322 Common Stock
Sep 13 2022	SELL Open market or private sale	$269,020 $136.42 p/Share	1,972 Reduced 0.12%	1,625,800 Common Stock
Sep 13 2022	BUY Exercise of conversion of derivative security	$21,495 $10.9 p/Share	1,972 Added 0.12%	1,627,772 Common Stock
Sep 12 2022	SELL Open market or private sale	$708,300 $141.66 p/Share	5,000 Reduced 0.31%	1,625,800 Common Stock
Sep 12 2022	BUY Exercise of conversion of derivative security	$54,500 $10.9 p/Share	5,000 Added 0.31%	1,630,800 Common Stock
Aug 29 2022	SELL Open market or private sale	$151,971 $135.81 p/Share	1,119 Reduced 0.07%	1,625,800 Common Stock
Aug 26 2022	BUY Exercise of conversion of derivative security	-	2,410 Added 0.15%	1,626,919 Common Stock
Aug 24 2022	SELL Open market or private sale	$714,000 $142.8 p/Share	5,000 Reduced 0.31%	1,624,509 Common Stock
Aug 24 2022	BUY Exercise of conversion of derivative security	$54,500 $10.9 p/Share	5,000 Added 0.31%	1,629,509 Common Stock
Aug 23 2022	SELL Open market or private sale	$708,500 $141.7 p/Share	5,000 Reduced 0.31%	1,624,509 Common Stock

Also insider at

AXLA

Axcella Health Inc. Healthcare

Director

Stephen Hoge

President

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account